REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,175 | +108650.0% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 300 | -50.0% | 0.00% | – |
| Q1 2022 | $4,000 | +300.0% | 600 | +100.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 367,346 | $926,000 | 0.15% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,950,002 | $4,914,000 | 0.11% |
| Claret Asset Management Corp | 95,430 | $240,000 | 0.05% |
| Annandale Capital, LLC | 43,532 | $110,000 | 0.04% |
| ARK Investment Management | 861,798 | $2,172,000 | 0.01% |
| Virtu Financial LLC | 26,864 | $68,000 | 0.01% |
| Ancora Advisors LLC | 82,048 | $207,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 4,600 | $1,372,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 25,499 | $64,000 | 0.00% |
| ATTICUS WEALTH MANAGEMENT, LLC | 2,425 | $6,000 | 0.00% |